LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | BX-912 | 3.33 | uM | LJP5 | 1 | L20 | 72 | hr | 658 | 858 | 3908 | 0.2195 | 0.1087 |
Hs 578T | BX-912 | 3.33 | uM | LJP5 | 2 | L20 | 72 | hr | 658 | 860 | 3953 | 0.2175 | 0.1089 |
Hs 578T | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 658 | 867 | 3938 | 0.2201 | 0.1127 |
Hs 578T | BX-912 | 10 | uM | LJP5 | 1 | L19 | 72 | hr | 658 | 535 | 3908 | 0.1369 | -0.0775 |
Hs 578T | BX-912 | 10 | uM | LJP5 | 2 | L19 | 72 | hr | 658 | 572 | 3953 | 0.1447 | -0.0528 |
Hs 578T | BX-912 | 10 | uM | LJP5 | 3 | L19 | 72 | hr | 658 | 610 | 3938 | 0.1549 | -0.0290 |
Hs 578T | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 658 | 2553 | 3705 | 0.6889 | 0.7223 |
Hs 578T | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 658 | 2691 | 3807 | 0.7068 | 0.7438 |
Hs 578T | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 658 | 2590 | 3769 | 0.6871 | 0.7230 |
Hs 578T | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 658 | 2246 | 3705 | 0.6061 | 0.6361 |
Hs 578T | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 658 | 2499 | 3807 | 0.6563 | 0.6936 |
Hs 578T | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 658 | 2159 | 3769 | 0.5727 | 0.6029 |
Hs 578T | Selumetinib | 0.37 | uM | LJP6 | 1 | M10 | 72 | hr | 658 | 1963 | 3705 | 0.5297 | 0.5500 |
Hs 578T | Selumetinib | 0.37 | uM | LJP6 | 2 | M10 | 72 | hr | 658 | 2002 | 3807 | 0.5258 | 0.5516 |
Hs 578T | Selumetinib | 0.37 | uM | LJP6 | 3 | M10 | 72 | hr | 658 | 1964 | 3769 | 0.5210 | 0.5437 |
Hs 578T | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 658 | 1825 | 3705 | 0.4925 | 0.5054 |
Hs 578T | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 658 | 1823 | 3807 | 0.4788 | 0.4953 |
Hs 578T | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 658 | 1736 | 3769 | 0.4605 | 0.4699 |
Hs 578T | Selumetinib | 3.33 | uM | LJP6 | 1 | M08 | 72 | hr | 658 | 1553 | 3705 | 0.4191 | 0.4110 |
Hs 578T | Selumetinib | 3.33 | uM | LJP6 | 2 | M08 | 72 | hr | 658 | 1623 | 3807 | 0.4263 | 0.4282 |
Hs 578T | Selumetinib | 3.33 | uM | LJP6 | 3 | M08 | 72 | hr | 658 | 1428 | 3769 | 0.3788 | 0.3602 |
Hs 578T | Selumetinib | 10 | uM | LJP6 | 1 | M07 | 72 | hr | 658 | 1203 | 3705 | 0.3246 | 0.2737 |
Hs 578T | Selumetinib | 10 | uM | LJP6 | 2 | M07 | 72 | hr | 658 | 1240 | 3807 | 0.3257 | 0.2842 |
Hs 578T | Selumetinib | 10 | uM | LJP6 | 3 | M07 | 72 | hr | 658 | 1206 | 3769 | 0.3199 | 0.2719 |
Hs 578T | MK2206 | 0.04 | uM | LJP6 | 1 | F06 | 72 | hr | 658 | 3241 | 3705 | 0.8746 | 0.8953 |